Fredag 30 Oktober | 04:05:42 Europe / Stockholm
Est. tid*
2027-10-29 21:05 Kvartalsrapport 2027-Q3
2027-07-29 21:05 Kvartalsrapport 2027-Q2
2027-04-29 21:05 Kvartalsrapport 2027-Q1
2027-01-28 N/A Bokslutskommuniké 2026
2026-10-29 - Kvartalsrapport 2026-Q3
2026-09-30 - X-dag kvartalsutdelning SYK 0.88
2026-07-30 - Kvartalsrapport 2026-Q2
2026-06-30 - X-dag kvartalsutdelning SYK 0.88
2026-05-06 - Årsstämma
2026-04-30 - Kvartalsrapport 2026-Q1
2026-03-31 - X-dag kvartalsutdelning SYK 0.88
2026-01-29 - Bokslutskommuniké 2025
2025-12-31 - X-dag kvartalsutdelning SYK 0.88
2025-10-30 - Kvartalsrapport 2025-Q3
2025-09-30 - X-dag kvartalsutdelning SYK 0.84
2025-07-31 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag kvartalsutdelning SYK 0.84
2025-05-08 - Årsstämma
2025-05-01 - Kvartalsrapport 2025-Q1
2025-03-31 - X-dag kvartalsutdelning SYK 0.84
2025-01-28 - Bokslutskommuniké 2024
2024-12-31 - X-dag kvartalsutdelning SYK 0.84
2024-10-29 - Kvartalsrapport 2024-Q3
2024-09-30 - X-dag kvartalsutdelning SYK 0.8
2024-07-30 - Kvartalsrapport 2024-Q2
2024-06-28 - X-dag kvartalsutdelning SYK 0.8
2024-05-09 - Årsstämma
2024-04-30 - Kvartalsrapport 2024-Q1
2024-03-28 - X-dag kvartalsutdelning SYK 0.8
2024-01-30 - Bokslutskommuniké 2023
2023-12-28 - X-dag kvartalsutdelning SYK 0.8
2023-11-02 - Kvartalsrapport 2023-Q3
2023-09-28 - X-dag kvartalsutdelning SYK 0.75
2023-08-03 - Kvartalsrapport 2023-Q2
2023-06-29 - X-dag kvartalsutdelning SYK 0.75
2023-05-10 - Årsstämma
2023-05-01 - Kvartalsrapport 2023-Q1
2023-03-30 - X-dag kvartalsutdelning SYK 0.75
2023-01-31 - Bokslutskommuniké 2022
2022-12-29 - X-dag kvartalsutdelning SYK 0.75
2022-10-31 - Kvartalsrapport 2022-Q3
2022-09-29 - X-dag kvartalsutdelning SYK 0.695
2022-07-26 - Kvartalsrapport 2022-Q2
2022-06-29 - X-dag kvartalsutdelning SYK 0.695
2022-05-04 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-03-30 - X-dag kvartalsutdelning SYK 0.695
2021-12-30 - X-dag kvartalsutdelning SYK 0.695
2021-10-28 - Kvartalsrapport 2021-Q3
2021-09-29 - X-dag kvartalsutdelning SYK 0.63
2021-07-27 - Kvartalsrapport 2021-Q2
2021-06-29 - X-dag kvartalsutdelning SYK 0.63
2021-05-06 - Årsstämma
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-30 - X-dag kvartalsutdelning SYK 0.63
2021-01-27 - Bokslutskommuniké 2020
2020-12-30 - X-dag kvartalsutdelning SYK 0.63
2020-10-29 - Kvartalsrapport 2020-Q3
2020-09-29 - X-dag kvartalsutdelning SYK 0.575
2020-07-30 - Kvartalsrapport 2020-Q2
2020-06-29 - X-dag kvartalsutdelning SYK 0.575
2020-05-05 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-03-30 - X-dag kvartalsutdelning SYK 0.575
2020-01-28 - Bokslutskommuniké 2019
2019-12-30 - X-dag kvartalsutdelning SYK 0.575
2019-09-27 - X-dag kvartalsutdelning SYK 0.52
2019-07-23 - Kvartalsrapport 2019-Q2
2019-04-23 - Kvartalsrapport 2019-Q1
LandUSA
Lista70
SektorHälsovård
IndustriMedicinteknik
Stryker är verksamt inom medicinteknik. Bolaget erbjuder produkter och tjänster inom ortopedi, samt medicinsk - och kirurgisk terapibehandling. Bolagets produktutbuded inkluderar utrustning för akutmottagningar, kirurgisk utrustning samt endoskopiska system. Strykers verksamhet innehas på global nivå. Bolaget grundades år 1946 och har huvudkontor i Kalamazoo.

All ägardata du vill ha finns i Holdings!

Stryker names Nick Mead Vice President, Investor Relations

2026-03-31 14:00:00

Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026.

Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker’s Medical division, where he partnered closely with senior leaders to support commercial strategy, capital allocation and operational execution.

“Nick brings deep institutional knowledge, strong financial expertise and a proven ability to support strategic decision making across the organization,” said Preston Wells, Vice President, Chief Financial Officer, Stryker. “His broad experience across our businesses and his strong relationships with internal and external stakeholders position him well to lead our investor relations function as we continue to execute our strategy and deliver value for shareholders.”

Since joining Stryker, Mead has held a variety of roles across the finance organization, supporting businesses within Endoscopy, Medical and Neurotechnology, Orthopaedics and Spine. Throughout his career, he has played a key role in commercial planning, investment decisions and mergers and acquisitions, supporting growth across implants, capital and service portfolios.

Jason Beach, Vice President, Finance and Investor Relations, has been named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology. Beach joined Stryker in 2018, serving as Vice President, Finance for Stryker’s Instruments division, where he supported strong business performance and led multiple acquisitions and finance transformation initiatives. He is a proven finance leader, recognized for his strong operational leadership, strategic insight and collaborative approach.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com